BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16397864)

  • 1. Sequential genome-wide association studies for monitoring adverse events in the clinical evaluation of new drugs.
    Kelly P; Stallard N; Zhou Y; Whitehead J; Bowman C
    Stat Med; 2006 Sep; 25(18):3081-92. PubMed ID: 16397864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequentially testing for a gene-drug interaction in a genomewide analysis.
    Kelly P; Zhou Y; Whitehead J; Stallard N; Bowman C
    Stat Med; 2008 May; 27(11):2022-34. PubMed ID: 17979181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpreting P values in pharmacogenetic studies: a call for process and perspective.
    Maitland ML; Ratain MJ; Cox NJ
    J Clin Oncol; 2007 Oct; 25(29):4513-5. PubMed ID: 17925544
    [No Abstract]   [Full Text] [Related]  

  • 5. Primer: SNP-associated studies and what they can teach us.
    Yamada R
    Nat Clin Pract Rheumatol; 2008 Apr; 4(4):210-7. PubMed ID: 18319711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dealing with adverse effects in phase I trials].
    Heger-Mahn D; Mahler M; Hermann R; Nowak H; Weber W; Seibert-Grafe M
    Arzneimittelforschung; 1995 Mar; 45(3):331-6. PubMed ID: 7741796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in high-density whole genome-wide single nucleotide polymorphism array in cancer research].
    Zeng ZY; Xiong W; Zhou YH; Li XL; Li GY
    Ai Zheng; 2006 Nov; 25(11):1454-8. PubMed ID: 17094921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal false discovery rate estimation methodology for genome-wide association studies.
    Forner K; Lamarine M; Guedj M; Dauvillier J; Wojcik J
    Hum Hered; 2008; 65(4):183-94. PubMed ID: 18073488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics and active surveillance for serious adverse drug reactions in children.
    Loo TT; Ross CJ; Sistonen J; Visscher H; Madadi P; Koren G; Hayden MR; Carleton BC
    Pharmacogenomics; 2010 Sep; 11(9):1269-85. PubMed ID: 20860467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting AIDS restriction genes: from candidate genes to genome-wide association discovery.
    Hutcheson HB; Lautenberger JA; Nelson GW; Pontius JU; Kessing BD; Winkler CA; Smith MW; Johnson R; Stephens R; Phair J; Goedert JJ; Donfield S; O'Brien SJ
    Vaccine; 2008 Jun; 26(24):2951-65. PubMed ID: 18325640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions.
    Nelson MR; Bacanu SA; Mosteller M; Li L; Bowman CE; Roses AD; Lai EH; Ehm MG
    Pharmacogenomics J; 2009 Feb; 9(1):23-33. PubMed ID: 18301416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On multiple-testing correction in genome-wide association studies.
    Moskvina V; Schmidt KM
    Genet Epidemiol; 2008 Sep; 32(6):567-73. PubMed ID: 18425821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.
    Grant SF; Hakonarson H
    Expert Rev Mol Diagn; 2007 Jul; 7(4):371-93. PubMed ID: 17620046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genome-wide association studies].
    Feenstra B; Boyd HA; Melbye M
    Ugeskr Laeger; 2008 Oct; 170(41):3216-20. PubMed ID: 18940150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of whole-genome association scans in disease gene identification, drug discovery and development.
    Roses AD; St Jean PL; Ehm MG
    IDrugs; 2007 Nov; 10(11):797-804. PubMed ID: 17968762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A gene-centric approach to genome-wide association studies.
    Jorgenson E; Witte JS
    Nat Rev Genet; 2006 Nov; 7(11):885-91. PubMed ID: 17047687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association study.
    Horne BD; Carlquist JF; Muhlestein JB; Nicholas ZP; Anderson JL;
    Am Heart J; 2007 Nov; 154(5):969-75. PubMed ID: 17967605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of SNP subsets for association studies in candidate genes: comparison of the power of different strategies to detect single disease susceptibility locus effects.
    Cousin E; Deleuze JF; Genin E
    BMC Genet; 2006 Apr; 7():20. PubMed ID: 16597333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting and interpretation in genome-wide association studies.
    Wakefield J
    Int J Epidemiol; 2008 Jun; 37(3):641-53. PubMed ID: 18270206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis.
    Mushiroda T; Wattanapokayakit S; Takahashi A; Nukiwa T; Kudoh S; Ogura T; Taniguchi H; Kubo M; Kamatani N; Nakamura Y;
    J Med Genet; 2008 Oct; 45(10):654-6. PubMed ID: 18835860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.